Integrated Advisors Network’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $618K | Buy |
1,523
+75
| +5% | +$30.4K | 0.03% | 449 |
|
|
2025
Q1 | $721K | Sell |
1,448
-56
| -4% | -$27.9K | 0.04% | 373 |
|
|
2024
Q4 | $782K | Sell |
1,504
-128
| -8% | -$66.6K | 0.04% | 346 |
|
|
2024
Q3 | $1.01M | Sell |
1,632
-274
| -14% | -$169K | 0.05% | 308 |
|
|
2024
Q2 | $1.05M | Buy |
1,906
+179
| +10% | +$99K | 0.05% | 296 |
|
|
2024
Q1 | $1M | Buy |
1,727
+206
| +14% | +$120K | 0.05% | 306 |
|
|
2023
Q4 | $807K | Sell |
1,521
-186
| -11% | -$98.7K | 0.05% | 321 |
|
|
2023
Q3 | $864K | Sell |
1,707
-248
| -13% | -$126K | 0.05% | 302 |
|
|
2023
Q2 | $1.02M | Sell |
1,955
-107
| -5% | -$55.8K | 0.06% | 284 |
|
|
2023
Q1 | $1.19M | Sell |
2,062
-111
| -5% | -$64K | 0.07% | 259 |
|
|
2022
Q4 | $1.2M | Sell |
2,173
-376
| -15% | -$207K | 0.08% | 256 |
|
|
2022
Q3 | $1.29M | Sell |
2,549
-349
| -12% | -$177K | 0.09% | 236 |
|
|
2022
Q2 | $1.57M | Sell |
2,898
-431
| -13% | -$234K | 0.1% | 216 |
|
|
2022
Q1 | $1.97M | Sell |
3,329
-269
| -7% | -$159K | 0.12% | 194 |
|
|
2021
Q4 | $2.4M | Buy |
3,598
+78
| +2% | +$52.1K | 0.14% | 164 |
|
|
2021
Q3 | $2.01M | Buy |
3,520
+135
| +4% | +$77.1K | 0.13% | 171 |
|
|
2021
Q2 | $1.71M | Buy |
3,385
+120
| +4% | +$60.5K | 0.13% | 170 |
|
|
2021
Q1 | $1.49M | Buy |
3,265
+14
| +0.4% | +$6.39K | 0.14% | 162 |
|
|
2020
Q4 | $1.51M | Sell |
3,251
-69
| -2% | -$32.1K | 0.17% | 149 |
|
|
2020
Q3 | $1.47M | Buy |
3,320
+67
| +2% | +$29.6K | 0.19% | 134 |
|
|
2020
Q2 | $1.18M | Buy |
3,253
+579
| +22% | +$210K | 0.14% | 170 |
|
|
2020
Q1 | $758K | Sell |
2,674
-1,675
| -39% | -$475K | 0.15% | 153 |
|
|
2019
Q4 | $1.41M | Buy |
+4,349
| New | +$1.41M | 0.19% | 158 |
|